Posaconazole and Pulmonary embolism - a phase IV clinical study of FDA data

Summary:

Pulmonary embolism is reported as a side effect among people who take Posaconazole (posaconazole), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Bactrim, and have Graft versus host disease.

The phase IV clinical study analyzes which people have Pulmonary embolism when taking Posaconazole. It is created by eHealthMe based on reports of 9,473 people who have side effects when taking Posaconazole from the FDA, and is updated regularly.

What is Posaconazole?

Posaconazole has active ingredients of posaconazole. eHealthMe is studying from 9,475 Posaconazole users. Check the latest studies of Posaconazole.

What is Pulmonary embolism?

Pulmonary embolism (blockage of the main artery of the lung) is found to be associated with 2,333 drugs and 2,956 conditions by eHealthMe. Check the latest studies of Pulmonary embolism.

On Jul, 16, 2026

9,473 people reported to have side effects when taking Posaconazole.
Among them, 56 people (0.59%) have Pulmonary embolism.

Could Posaconazole cause Pulmonary embolism?

Among these 56 people:

How long have people been on Posaconazole when they have Pulmonary embolism? *

What is the gender of people who have Pulmonary embolism when taking Posaconazole? *

female: 14.89 %
male: 85.11 %

What is the age of people who have Pulmonary embolism when taking Posaconazole? *

What are other drugs people take besides Posaconazole? *

Prednisone: 16 people, 28.57%
Bactrim: 16 people, 28.57%
Acyclovir: 12 people, 21.43%
Ursodiol: 11 people, 19.64%
Jakafi: 10 people, 17.86%
Amlodipine: 9 people, 16.07%
Potassium Chloride: 7 people, 12.50%
Amoxicillin: 7 people, 12.50%
Leucovorin Calcium: 7 people, 12.50%
Valacyclovir Hydrochloride: 7 people, 12.50%

What are other side effects people have besides Pulmonary embolism? *

Pneumonia: 14 people, 25.00%
Thrombocytopenia (decrease of platelets in blood): 10 people, 17.86%
Leukopenia (less number of white blood cells in blood): 8 people, 14.29%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 8 people, 14.29%
Pleural Effusion (water on the lungs): 8 people, 14.29%
Enterococcal Infection: 8 people, 14.29%
Fatigue (feeling of tiredness): 7 people, 12.50%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 7 people, 12.50%
Oedema Peripheral (superficial swelling): 7 people, 12.50%
Nosebleed (bleeding from nose): 7 people, 12.50%

What are the existing conditions these people have? *

Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 13 people, 23.21%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 7 people, 12.50%
Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 6 people, 10.71%
Immunodeficiency Disorders: 6 people, 10.71%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 6 people, 10.71%
High Blood Pressure: 5 people, 8.93%
Pain: 5 people, 8.93%
Fungal Infection: 3 people, 5.36%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 5.36%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 2 people, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Posaconazole and have Pulmonary embolism?

- Check whether Pulmonary embolism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Posaconazole:

Posaconazole (9,475 reports)

Browse all side effects of Posaconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary embolism:

Pulmonary embolism (2,333 drugs)

Browse all the conditions that are associated with Pulmonary embolism:

Pulmonary embolism (2,956 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on posaconazole (the active ingredients of Posaconazole) and Posaconazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.